601607 上海医药
2025/03 - 三个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(2,204,316)5,827,2585,231,5204,743,3615,061,326
投资活动产生之现金流量净额(972,937)415,980(2,491,873)(12,473,124)(6,015,576)
筹资活动产生之现金流量净额3,864,209(1,863,930)231,85112,138,5941,565,628
汇率变动对现金及现金等价物的影响4,0392,157(5,580)(12,440)(50,323)
现金及现金等价物净增加/(减少)690,9954,381,4642,965,9184,396,391561,055
期初现金及现金等价物余额31,881,27327,499,80924,533,89120,137,50019,576,445
期末现金及现金等价物余额32,572,26731,881,27327,499,80924,533,89120,137,500